The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
The key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry thought-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 67 countries.
North Carolina Reception at BIO 2019
June 4, 2019
6:00 – 9:00 pm
2025 Benjamin Franklin Parkway
We invite you to join us for an evening reception on June 4 at The Barnes Foundation. Network with NCBiotech and other life science leaders all while enjoying delicious food and fine art.
Opportunities to Connect with NCBiotech
NCBiotech will highlight North Carolina's expertise and global leadership at the following sessions.
Global Innovation Hub: North Carolina, USA
Tuesday, June 4 | 2:30 p.m. | Theater 4, Second Floor
Mary Hecht-Kissell, Director, Business Development
Learn what North Carolina has to offer as a leading life science hub and why we're ranked a top place to do business.
Personalized Medicine and Diagnostics
Innovative Models for Real World Evidence: Creating Value-Based Precision Health
Wednesday, June 5 | 1:45-2:45 p.m. | Room 116
Moderated by: Sara Imhof, Ph.D., Senior Director, Precision Health, NCBiotech
Payers are evaluating provider and reimbursement policies, seeking value in precision health. This is shifting paradigms in precision health innovation, favoring models with strategic and agile approaches to discovery research, translation and implementation. These models emphasize partnerships and commitments around evidence thresholds upstream of data collection, and they are demonstrating the potential and promise of precision health for transforming clinical care.
During this session, Vital Innovation and Alva10 will present new and emerging pathways for generating this real world evidence, while Optum will highlight the payer perspective and role for researcher, industry and payer collaborations.
Business Development and Finance
Technology-Based Economic Development: Evolving Models, Strategies and Finance Approaches
Wednesday, June 5 | 3-4:00 p.m. | Room 109AB
Doug Edgeton, President and CEO, NCBiotech
While life sciences directed technology-based economic development (TBED) organizations have multiplied over the last 40 years, their missions are similar and largely unchanged - to drive regional economic development in the life sciences. Many leading organizations have adopted roles as direct or indirect investors in innovation at all stages of development. These investments - ranging from traditional grants, loans and tax credits to equity vehicles, seeding public/private partnerships and other emerging investment models - are designed to grow their innovation pipelines and generate economic and financial returns for their primary funders.
Representatives from four of the nation’s premier life sciences TBED organizations will discuss the evolution of their models and their current approaches for delivering impact to their funders and constituents.
View the full BIO 2019 schedule.
Pennsylvania Convention Center
1101 Arch St.
Philadelphia, PA 19107